Aeterna (M.AEL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aeterna (M.AEL)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DaveAu who wrote (28)	2/25/2000 6:55:00 PM
From: DaveAu	Read Replies (1) of 47

From bloomberg: Aeterna Raised to 'Strong Buy' at Yorkton Securities Toronto, Feb. 22 (Bloomberg Data) -- Aeterna Laboratoires Inc. (AEL CN) was raised to ''strong buy'' from ''accumulate'' by analyst Ezra S. Lwowski at Yorkton Securities. The 12-to-18-month target price is C$23.00 per share. Aeterna Laboratoires Reiterated 'Buy' at BLC Securities Toronto, Feb. 23 (Bloomberg Data) -- Aeterna Laboratoires Inc. (AEL CN) was reiterated ''buy'' by analysts Genevieve Poulin, Benoit Caron and Samir Taga at BLC Securities. The 12-month target price is C$22.00 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next